236 related articles for article (PubMed ID: 22011484)
1. Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes.
Katoch D; Sanghi G; Dogra MR; Beke N; Gupta A
Indian J Ophthalmol; 2011; 59(6):423-6. PubMed ID: 22011484
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
[TBL] [Abstract][Full Text] [Related]
3. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age.
Quinn GE; Dobson V; Davitt BV; Hardy RJ; Tung B; Pedroza C; Good WV;
Ophthalmology; 2008 Jun; 115(6):1058-1064.e1. PubMed ID: 18423871
[TBL] [Abstract][Full Text] [Related]
4. Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study.
Wheeler DT; Dobson V; Chiang MF; Bremer DL; Gewolb IH; Phelps DL; Hardy RJ; Good WV; Fellows R; Tung BP; Palmer EA
Ophthalmology; 2011 Jun; 118(6):1145-51. PubMed ID: 21211840
[TBL] [Abstract][Full Text] [Related]
5. Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age.
Davitt BV; Dobson V; Quinn GE; Hardy RJ; Tung B; Good WV;
Ophthalmology; 2009 Feb; 116(2):332-9. PubMed ID: 19091409
[TBL] [Abstract][Full Text] [Related]
6. Outcome of solid-state 532 nm green laser in high-risk retinopathy of prematurity at a tertiary care centre in India.
Chhabra K; Kaur P; Singh K; Aggarwal A; Chalia D
Int Ophthalmol; 2018 Feb; 38(1):287-291. PubMed ID: 28204988
[TBL] [Abstract][Full Text] [Related]
7. One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.
Gunay M; Celik G; Ovali F; Yetik H; Aktas A; Gunay BO
Int Ophthalmol; 2015 Feb; 35(1):27-35. PubMed ID: 25381161
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Intensive Care Unit-based screening program for retinopathy of prematurity and its treatment in an Indian population.
Goyal A; Giridhar A; Gopalakrishnan M; Thachil T
Indian J Ophthalmol; 2019 Jun; 67(6):828-833. PubMed ID: 31124496
[TBL] [Abstract][Full Text] [Related]
9. Does the number of laser applications for ROP treatment influence the degree of myopia?
Inoue T; Asaoka R; Hashimoto Y; Kitamoto K; Kitano M; Fujita A; Azuma K; Yamamoto K; Nagahara M; Kadonosono K; Obata R
Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):317-322. PubMed ID: 32978662
[TBL] [Abstract][Full Text] [Related]
10. Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age.
Davitt BV; Quinn GE; Wallace DK; Dobson V; Hardy RJ; Tung B; Lai D; Good WV;
Ophthalmology; 2011 Dec; 118(12):2326-9. PubMed ID: 21872933
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
[TBL] [Abstract][Full Text] [Related]
12. Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?
Kıran Yenice E; Kara C
Int Ophthalmol; 2023 May; 43(5):1453-1458. PubMed ID: 36149616
[TBL] [Abstract][Full Text] [Related]
13. Refractive outcome of prethreshold retinopathy of prematurity treated by diode laser: follow-up at 5 years.
Nguyen PH; Catt C; Nguyen TX; Pham VT
Clin Ophthalmol; 2015; 9():1753-8. PubMed ID: 26445521
[TBL] [Abstract][Full Text] [Related]
14. Refractive status of Chinese with laser-treated retinopathy of prematurity.
Ruan L; Shan HD; Liu XZ; Huang X
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S3-9. PubMed ID: 25756334
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Quinn GE; Dobson V; Kivlin J; Kaufman LM; Repka MX; Reynolds JD; Gordon RA; Hardy RJ; Tung B; Stone RA
Ophthalmology; 1998 Jul; 105(7):1292-300. PubMed ID: 9663236
[TBL] [Abstract][Full Text] [Related]
16. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
Geloneck MM; Chuang AZ; Clark WL; Hunt MG; Norman AA; Packwood EA; Tawansy KA; Mintz-Hittner HA;
JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848
[TBL] [Abstract][Full Text] [Related]
17. Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.
Lok JYC; Yip WWK; Luk ASW; Chin JKY; Lau HHW; Young AL
Int Ophthalmol; 2018 Feb; 38(1):163-169. PubMed ID: 28054213
[TBL] [Abstract][Full Text] [Related]
18. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.
Early Treatment For Retinopathy Of Prematurity Cooperative Group
Arch Ophthalmol; 2003 Dec; 121(12):1684-94. PubMed ID: 14662586
[TBL] [Abstract][Full Text] [Related]
19. One-year visual outcomes after laser for Type 1 prethreshold retinopathy of prematurity among very low birth weight neonates at a tertiary center in western India - A prospective cohort study.
Halan P; Garg BD
J Matern Fetal Neonatal Med; 2020 May; 33(9):1561-1565. PubMed ID: 30642206
[No Abstract] [Full Text] [Related]
20. Posterior to the ridge laser in zone 2 stage 3 retinopathy of prematurity with plus disease: Efficacy and safety.
Sanghi G; Gupta R; Narula S
Indian J Ophthalmol; 2023 Nov; 71(11):3501-3505. PubMed ID: 37870014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
